These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15615692)

  • 1. Molecular basis of exopeptidase activity in the C-terminal domain of human angiotensin I-converting enzyme: insights into the origins of its exopeptidase activity.
    Naqvi N; Liu K; Graham RM; Husain A
    J Biol Chem; 2005 Feb; 280(8):6669-75. PubMed ID: 15615692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides.
    Jaspard E; Wei L; Alhenc-Gelas F
    J Biol Chem; 1993 May; 268(13):9496-503. PubMed ID: 7683654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site.
    Danilov S; Jaspard E; Churakova T; Towbin H; Savoie F; Wei L; Alhenc-Gelas F
    J Biol Chem; 1994 Oct; 269(43):26806-14. PubMed ID: 7523412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo.
    Fuchs S; Xiao HD; Hubert C; Michaud A; Campbell DJ; Adams JW; Capecchi MR; Corvol P; Bernstein KE
    Hypertension; 2008 Feb; 51(2):267-74. PubMed ID: 18158355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.
    Araujo MC; Melo RL; Cesari MH; Juliano MA; Juliano L; Carmona AK
    Biochemistry; 2000 Jul; 39(29):8519-25. PubMed ID: 10913258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.
    Larmuth KM; Masuyer G; Douglas RG; Schwager SL; Acharya KR; Sturrock ED
    FEBS J; 2016 Mar; 283(6):1060-76. PubMed ID: 26748546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition.
    Lubbe L; Sewell BT; Sturrock ED
    FEBS J; 2016 Nov; 283(21):3941-3961. PubMed ID: 27636235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE).
    Yates CJ; Masuyer G; Schwager SL; Akif M; Sturrock ED; Acharya KR
    J Biol Chem; 2014 Jan; 289(3):1798-814. PubMed ID: 24297181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice.
    Fuchs S; Xiao HD; Cole JM; Adams JW; Frenzel K; Michaud A; Zhao H; Keshelava G; Capecchi MR; Corvol P; Bernstein KE
    J Biol Chem; 2004 Apr; 279(16):15946-53. PubMed ID: 14757757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the C-domain-selective angiotensin-converting enzyme inhibition by bradykinin-potentiating peptide b (BPPb).
    Sturrock ED; Lubbe L; Cozier GE; Schwager SLU; Arowolo AT; Arendse LB; Belcher E; Acharya KR
    Biochem J; 2019 May; 476(10):1553-1570. PubMed ID: 31072910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
    Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
    Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme open for business: structural insights into the subdomain dynamics.
    Cozier GE; Lubbe L; Sturrock ED; Acharya KR
    FEBS J; 2021 Apr; 288(7):2238-2256. PubMed ID: 33067882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin I-converting enzyme transition state stabilization by HIS1089: evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases.
    Fernandez M; Liu X; Wouters MA; Heyberger S; Husain A
    J Biol Chem; 2001 Feb; 276(7):4998-5004. PubMed ID: 11067854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides.
    Cotton J; Hayashi MA; Cuniasse P; Vazeux G; Ianzer D; De Camargo AC; Dive V
    Biochemistry; 2002 May; 41(19):6065-71. PubMed ID: 11994001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
    Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence and biochemical properties of a molluscan invertebrate angiotensin-converting enzyme.
    Laurent V; Stefano G; Salzet M
    Regul Pept; 1997 Mar; 69(2):53-61. PubMed ID: 9178346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arg(1098) is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity.
    Liu X; Fernandez M; Wouters MA; Heyberger S; Husain A
    J Biol Chem; 2001 Sep; 276(36):33518-25. PubMed ID: 11432860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.
    Woodman ZL; Oppong SY; Cook S; Hooper NM; Schwager SL; Brandt WF; Ehlers MR; Sturrock ED
    Biochem J; 2000 May; 347 Pt 3(Pt 3):711-8. PubMed ID: 10769174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.